Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 398 abstracts

no pagination
Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer. 2001 Nov 15;92(10):2639-47.
Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ. Chronic dosing of oltipraz in people at increased risk for colorectal cancer. Cancer Detect Prev. 2001 Jan;25(4):352-61.
Tapiero H, Tew KD, Gate L, Machover D. Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiency and requirements. Biomed Pharmacother. 2001 Sep;55(7):381-90.
Treat J, Damjanov N, Huang C, Zrada S, Rahman A. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. Oncology (Huntingt). 2001 May;15(5 Suppl 7):44-8.
von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res. 2001 May;7(5):1181-91.
Von Roenn JH, Cianfrocca M. Treatment of Kaposi's sarcoma. Cancer Treat Res. 2001 Jan;104:127-48.
Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys. 2001 Jan;51(3 Suppl 2):19-27.
Adams GP, Shaller CC, Chappell LL, Wu C, Horak EM, Simmons HH, Litwin S, Marks JD, Weiner LM, Brechbiel MW. Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules. Nucl Med Biol. 2000 May;27(4):339-46.
Baselli EC, Greenberg RE. Intravesical therapy for superficial bladder cancer. Oncology (Huntingt). 2000 May;14(5):719-29; discussion 729-31, 734, 737.
Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, Harper PG, Horvath G, Kaye SB, Luck HJ, Lund B, McGuire WP, Neijt JP, Ozols RF, Parmar MK, Piccart-Gebhart MJ, van Rijswijk R, Rosenberg P, Rustin GJ, Sessa C, Thigpen JT, Trope C, Tuxen MK, Vergote I, Vermorken JB, Willemse PH. [Epithelial ovarian cancer (advanced stage): consensus conference (1998)]. Gynecol Obstet Fertil. 2000 Jul;28(7-8):576-83.
Bookman MA, Blessing JA, Hanjani P, Herzog TJ, Andersen WA. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group. Gynecol Oncol. 2000 Jun;77(3):446-9.
Cheng JD, Rieger PT, von Mehren M, Adams GP, Weiner LM. Recent advances in immunotherapy and monoclonal antibody treatment of cancer. Semin Oncol Nurs. 2000 Nov;16(4 Suppl 1):2-12.
Coughlin C, Scott C, Langer C, Coia L, Curran W, Rubin P. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int J Radiat Oncol Biol Phys. 2000 Dec;48(5):1351-8.
Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 2000 Jul;47(4):883-94.
Friedman CD, Costantino PD, Synderman CH, Chow LC, Takagi S. Reconstruction of the frontal sinus and frontofacial skeleton with hydroxyapatite cement. Arch Facial Plast Surg. 2000 Apr;2(2):124-9.
Haas NB, Manola J, Hudes G, Citrin DL, Kies MS, Davis TE. Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer. Am J Clin Oncol. 2000 Dec;23(6):589-92.
Hanlon AL, Hanks GE. Failure patterns and hazard rates for failure suggest the cure of prostate cancer by external beam radiation. Urology. 2000 May;55(5):725-9.
Held-Warmkessel J. Methotrexate. Clinical journal of oncology nursing. 2000 Jul;4(4):187-8.
Horwitz EM, Hanks GE. External beam radiation therapy for prostate cancer. CA: a cancer journal for clinicians. 2000 Nov;50(6):349-75; quiz 376-9.
Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halberr T, Qian M, Gallo JM. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res. 2000 Aug;6(8):3071-80.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human drug therapy Male Female pathology Middle Age Aged administration & dosage US Gov't Support-PHS Adult adverse effects Non-US Gov't Support radiotherapy Antineoplastic Agents Neoplasms methods Combined Modality Therapy adverse blood Prostatic Neoplasms effects metabolism mortality 80 and over Aged Survival Analysis Antineoplastic Combined Chemotherapy Protocols Paclitaxel drug effects Prognosis Follow-Up Studies Patient Selection Clinical Trials nursing complications Antineoplastic Antimetabolites Severity of Illness Index US Gov't Support-Non-PHS Ovarian Neoplasms analogs & derivatives Animal surgery Interferons diagnosis Anticarcinogenic Agents Adjuvant Chemotherapy therapy genetics Cisplatin Oncologic Nursing secondary Treatment Outcome biosynthesis Doxorubicin Radiotherapy Dosage Breast Neoplasms Cohort Studies Infiltrating Duct Carcinoma Synthetic Vaccines Skin Neoplasms Radioimmunotherapy Middle Aged Intravesical Administration Disease Progression Professional Staff Committees Cytotoxins Mycobacterium bovis Human Herpesvirus 8 Frontal Sinus Drug Delivery Systems Transitional Cell Carcinoma Enzyme Induction Retinoids Facial Bones Dose Fractionation Glutathione Non-Small-Cell Lung Carcinoma Experimental Neoplasms use Tetrahydrofolate Dehydrogenase Oxidative Stress Mononuclear Leukocytes Bladder Neoplasms Cryotherapy Axilla Diet Metabolic Clearance Rate Folic Acid Deficiency Nude Mice Immunoglobulin Fragments Drug Interactions Viral Load Lymphatic Irradiation etiology Immunity Radiation Oncology Menopause therapeutic Bone Cements Brain Neoplasms physiopathology Oral Administration Adenocarcinoma Bismuth Practice Guidelines Nutritional Status Combination Drug Therapy Highly Active Antiretroviral Therapy Antineoplastic Antibiotics Methotrexate Reconstructive Surgical Procedures NAD(P)H Dehydrogenase (Quinone) Phytogenic Antineoplastic Agents Cultured Tumor Cells Fluorouracil Patient Education Residual Neoplasm Anthracyclines T-Lymphocytes Liposomes Homocysteine immunology Androgen Antagonists DNA Alkylating Antineoplastic Agents Immunologic Adjuvants Treatment Failure urine Physical Examination physiology organization & administration Drug Dose-Response Relationship Squamous Cell Carcinoma Multiple Drug Resistance Carmustine Respiratory Tract Neoplasms Biopsy Immunotherapy Risk Factors pharmacology CD4 Lymphocyte Count Phase I Clinical Trials Gastrointestinal Neoplasms Conformal Radiotherapy pharmacokinetics Forecasting Mitomycin Proto-Oncogene Protein p21(ras) Biological Tumor Markers Disease-Free Survival
Last updated on Friday, January 03, 2020